First, we found miR-301a was induced in both human and mouse PSCs after TGF-β or IL-6 treatment as well as in mouse embryonic fibroblast and pancreatic cancer cells (Figures 5H and 5I). The gene discussed is IL6; the disease is familial pancreatic carcinoma.